BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38568413)

  • 1. ZNF26-Associated Genes as Prognostic Signatures in Colorectal Cancer with Broad Therapeutic Implications.
    Lei X; Zhang L; Liu Y; Sun H; Yan J; Liu S
    J Appl Genet; 2024 Apr; ():. PubMed ID: 38568413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of
    Liu J; Li Y; Gan Y; Xiao Q; Tian R; Shu G; Yin G
    Front Cell Dev Biol; 2021; 9():671211. PubMed ID: 34178996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Model of Colorectal Cancer Constructed by Eight Immune-Related Genes.
    Wen S; He L; Zhong Z; Mi H; Liu F
    Front Mol Biosci; 2020; 7():604252. PubMed ID: 33330631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ano1 is a Prognostic Biomarker That is Correlated with Immune Infiltration in Colorectal Cancer.
    Chen J; Wang H; Peng F; Qiao H; Liu L; Wang L; Shang B
    Int J Gen Med; 2022; 15():1547-1564. PubMed ID: 35210827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NDUFA4L2 is a novel biomarker for colorectal cancer through bioinformatics analysis.
    Lin Y; Xie H; Zhao W; Li Y; Zhang Z
    Medicine (Baltimore); 2023 Nov; 102(44):e35893. PubMed ID: 37933010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SLC2A1 is a Diagnostic Biomarker Involved in Immune Infiltration of Colorectal Cancer and Associated With m6A Modification and ceRNA.
    Liu XS; Yang JW; Zeng J; Chen XQ; Gao Y; Kui XY; Liu XY; Zhang Y; Zhang YH; Pei ZJ
    Front Cell Dev Biol; 2022; 10():853596. PubMed ID: 35399515
    [No Abstract]   [Full Text] [Related]  

  • 7. Grid2 interacting protein is a potential biomarker related to immune infiltration in colorectal cancer.
    Zhao J; Quan J; Chen W; Xie X
    Eur J Med Res; 2023 Nov; 28(1):511. PubMed ID: 37964339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor microenvironment-related gene selenium-binding protein 1 (SELENBP1) is associated with immunotherapy efficacy and survival in colorectal cancer.
    Zhu C; Wang S; Du Y; Dai Y; Huai Q; Li X; Du Y; Dai H; Yuan W; Yin S; Wang H
    BMC Gastroenterol; 2022 Oct; 22(1):437. PubMed ID: 36253721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment and verification of prognostic model and ceRNA network analysis for colorectal cancer liver metastasis.
    Zhang X; Wu T; Zhou J; Chen X; Dong C; Guo Z; Yang R; Liang R; Feng Q; Hu R; Li Y; Ding R
    BMC Med Genomics; 2023 May; 16(1):99. PubMed ID: 37161577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal cancer with low SLC35A3 is associated with immune infiltrates and poor prognosis.
    Lu S; Sun X; Tang H; Yu J; Wang B; Xiao R; Qu J; Sun F; Deng Z; Li C; Yang P; Yang Z; Rao B
    Sci Rep; 2024 Jan; 14(1):329. PubMed ID: 38172565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The possible role of SRMS in colorectal cancer by bioinformatics analysis.
    Zhang J; Liu W; Feng S; Zhong B
    World J Surg Oncol; 2021 Nov; 19(1):326. PubMed ID: 34781983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Expression of FCRLB Predicts Poor Prognosis in Patients With Colorectal Cancer.
    Wang X; Lin R; Zeng Y; Wang Y; Wei S; Lin Z; Chen S; Ye Z; Chen L
    Front Genet; 2022; 13():882307. PubMed ID: 35783274
    [No Abstract]   [Full Text] [Related]  

  • 13. Construction of a 12-gene prognostic model for colorectal cancer based on heat shock protein-related genes.
    Tong Q; Zhou J
    Int J Hyperthermia; 2024; 41(1):2290913. PubMed ID: 38191150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated Analysis of Expression and Prognostic Values of Acyl-CoA Dehydrogenase short-chain in Colorectal Cancer.
    Wu Q; Yan T; Chen Y; Chang J; Jiang Y; Zhu D; Wei Y
    Int J Med Sci; 2021; 18(16):3631-3643. PubMed ID: 34790035
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic implications of metabolism-associated gene signatures in colorectal cancer.
    Miao Y; Li Q; Wang J; Quan W; Li C; Yang Y; Mi D
    PeerJ; 2020; 8():e9847. PubMed ID: 32953273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CILP2: A prognostic biomarker associated with immune infiltration in colorectal cancer.
    Wang X; Zhang Y; Song N; Li K; Lei S; Wang J; Wang Z; Zhang W
    Heliyon; 2023 May; 9(5):e15535. PubMed ID: 37144183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA profile study identifies a metabolism-related signature for colorectal cancer.
    Lu Y; Wang W; Liu Z; Ma J; Zhou X; Fu W
    Mol Med; 2021 Aug; 27(1):83. PubMed ID: 34344319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ring finger protein 215 is a potential prognostic biomarker involved in immune infiltration and angiogenesis in colorectal cancer.
    Wu JB; Li XJ; Liu H; Liu XP
    Biomed Rep; 2023 Jul; 19(1):50. PubMed ID: 37383678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer.
    Yue Y; Zhang Q; Sun Z
    Front Immunol; 2021; 12():758040. PubMed ID: 35140706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinicopathological and prognostic significances of IGF-1R and Livin expression in patients with colorectal cancer.
    Zhang Z; Zhang Y; Lao S; Qiu J; Pan Z; Feng X
    BMC Cancer; 2022 Aug; 22(1):855. PubMed ID: 35931997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.